Mohan Purushothaman is a thought leader in the Pharmaceutical Pricing, Reimbursement and Market Access space. He has several years of experience in the Pharma industry followed more than a decade of work as a strategic advisor to various pharmaceutical companies. After spending 5 years at Roche where he headed the pricing and contracting group, he built a successful practice at Net Margins and went on to lead a global practice at Alliance Life Sciences. In these challenging assignments, he guided the development of strategies for a number of products across multiple therapeutic areas and markets.
He has been an active entrepreneur and responsible for giving shape to multiple business concepts at the core of new business ventures over the last decade. As a co-founder and President of Progentec Diagnostics TM, he is actively involved in exploring and commercializing new technologies in the diagnostic and therapeutic areas.
He holds a Ph.D. from the Johns Hopkins University with a focus on Pharmaceutical Pricing. Prior to that, he was a Research Fellow at Harvard University.
Pharmaceutical executive with a blend of successful experience in large, mid-size and startups in North America and Asia, with national and global responsibility for various business functions including General Management, Sales & Marketing, Market Access & Development.
Launched two companies in US and have led product launches as well as life cycle management of major brands in both primary care and specialty space. Served as member of Executive committee and have a successful track record of developing agile and inventive business cultures capable of achieving ambitious, “big-pharma” scale marketing initiatives on thrifty budgets.
His most recent success as a Chief Commercial Officer was the US launch of Diclegis for Duchesnay, one of the top-performing new product launches of 2013, achieved through a highly effective market access initiative and ground-breaking digital strategies. His professional history reflects the ability to drive paradigm change using cost-effective and scalable strategies that fully leverage marketing resources, including virtual organization structure, KOL network activation, and skilled application of customer research.
Previously, Sanjiv served as SVP WW Commercial & Country Head for US for NicOx, a French-based pharmaceutical platform technology company, and before that, oversaw strategic marketing for Biovail. The prior 15 years were spent with Sanofi-Aventis, where Sanjiv rose from sales rep in Canada to become the Director Global Marketing, New Products Commercialization, Metabolism & Cardiovascular. There, he successfully drove global marketing strategy for Sanofi Aventis’ GLP-1 and its diabetes portfolio.
Sanjiv received BSc (Hons) from Delhi University in India and his MBA with Distinction, from the Richard Ivey School of at the University of Western Ontario, Canada.
Eldon Jupe, Ph.D, Head Lab Operations
Eldon bring over 30 years of experience in biochemistry, toxicology and human genetics. He co-founded InterGenetics Inc., and served as its VP, CSO and COO and raised more than $30M in financing and grants over time. He led a team that developed OncoVue® – a proprietary test for breast cancer . Eldon graduated magna cum laude from Texas A&M University with a BS in Biochemistry and an MS in Genetics. He holds a PhD in Biochemistry from Louisiana State University and completed Postdoctoral studies at the University of Cincinnati.
Sneha Nair, Senior Manager, Operations
Sneha brings with her strong experience in HR, operations, and project management. Having led a team of business analysts in executing projects in the healthcare domain, over the years she has also worked as a research consultant with various clients in finance and healthcare. Sneha holds an MBA in Human Resource Management.
Anthony Barnes, Ph.D., Chief Scientific Officer
Tony Barnes, Ph.D., MBA has spent the last 35 years as an executive in the pharmaceutical, medical diagnostic and bioinformatics industries. His major skills are in the specification, development and marketing of novel multivariate diagnostic tests involving the application of advanced statistical and machine learning techniques. He has previously managed the development of two automated immunoassay devices (Abbott and Ciba-Chiron), a blood glucose monitor (Lifescan), a liquid biopsy company (Immunicon-Veridex), a cytokine immunoassay company (Cytimmune Sciences), a cancer screening device dependent upon autoimmunity to tumor antigens (Oncimmune) and a schizophrenia diagnostic test (Myriad-RBM). Over the last 20 years, he has worked with several of the world’s most famous machine learning experts, applying novel techniques to make diagnostic and therapy prediction tools more understandable to physicians. Dr. Barnes has been the CEO of three companies, been involved with two IPO’s and two acquisitions. He holds a Ph.D. in analytical chemistry (UIUC) and an MBA from University of Chicago.
Ryan Newhardt, Clinical Study Coordinator
Ryan began his research career as an undergraduate researcher developing nanotechnology for the delivery of chemotherapy agents. He also gained clinical experience working as a Medical Assistant. Prior to joining the Progentec TM team, Ryan spent three years focused on patient recruitment and clinical trial reporting at the University of Oklahoma Health Sciences Center including managing the hospital’s participation in ‘Project: Every Child,’ the largest study of its kind aimed at enrolling all newly-diagnosed or relapsed pediatric oncology patients into an international registry. Ryan has a BS in Zoology from Oklahoma State University.
Arif Sorathia, Co-Head of Social Media and Digital Marketing
Arif, a co-founder of LupusCorner, has spent his career in data science and product development. He is a Product Strategist with a developer and solution architecture skillset with deep experience in analytics and software development. He has built predictive models and lead data science and product teams. Being the son of a physician and getting his degree in Biomedical Engineering instilled a deep passion for building tech that helps patients. Arif led the analytics and innovation practice at IBB prior to founding Karate Health. He currently co-leads Social Media initiatives relating to LupusCorner at Progentec TM where he is leading business and technical development efforts.
Brett Adelman, Co-Head of Social Media and Digital Marketing
Brett, a co-founder of LupusCorner has spent his entire career in healthcare IT and policy. He built workflows and worked with healthcare data first with Epic, a leading electronic medical health records company, then later as a consultant for Rady Children’s Hospital. Before founding Karate Health, Brett worked in healthcare policy. Brett has spent his entire career in healthcare IT and policy. He is leading product development and customer acquisition. Brett co-leads LupusCorner and leads the development activities involving workflow, healthcare strategies, graphic design, and developer related tasks. He brings significant experience in healthcare IT and policy.